CDNA earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E -238.96. Updated 2026-07-23.
CareDx (CDNA) Research Hub
CareDx (CDNA) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 50.26 USD (+0.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -238.96, market cap 1.95B. This hub links to the full technical, earnings and options research available for CDNA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 50.26 USD (+0.46%) |
| 52-week range | 22.73 USD – 52.38 USD |
| Trend regime | Range |
| 14-day RSI | 65.9 (Bullish) |
| Trailing P/E | -238.96 |
| Market cap | 1.95B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for CDNA
Covered Call on CDNA: how it works, illustrative setup around the real 50.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CDNA: how it works, illustrative setup around the real 50.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CDNA: how it works, illustrative setup around the real 50.26 USD price, max profit/loss, breakeven and when to use it. Educational.
CDNA technical analysis: range, last 50.26 USD, RSI 65.9, 52w range 22.73 USD–52.38 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CDNA in?
CareDx (CDNA) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is CDNA in an uptrend or downtrend?
As of 2026-09-11, CDNA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CDNA's trailing P/E ratio?
CDNA's trailing P/E is -238.96, with a market cap of 1.95B. See the earnings research page for full valuation detail.
When does CDNA next report earnings?
CDNA is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 0.22 USD.